Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy

BMC Gastroenterology

Urban Sjoqvist¹  Greger Lindberg²  Charlotte M Hoog¹ 

[1]Stockholm South Hospital, Karolinska Institutet, Stockholm, Sweden

[2]Karolinska Institutet, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden

Others  :  1211642
DOI  :  10.1186/1471-230X-7-29

 received in 2007-01-22, accepted in 2007-07-18,  发布年份 2007

【 摘 要 】

Background

Capsule endoscopy (CE) is a unique tool to visualize the mucosa of the small intestine. Chronic intestinal dysmotility (CID) is a group of rare disorders of gastrointestinal motility that often are complicated by bacterial overgrowth. The aim of this study was to determine the prevalence of small bowel mucosal abnormalities in patients with CID. We also studied the usefulness of CE in the diagnosis of intestinal dysmotility.

Methods

We conducted a prospective study using CE in 18 patients; six with myopathic, 11 with neuropathic and one with indeterminate CID. A control group was used for comparison of small bowel transit.

Results

Mucosal breaks (erosions and ulcerations) were found in 16/18 (89%) patients. The capsule reached the caecum in 11/18 (61%) patients with a median transit time of 346 minutes. In the control group the capsule reached the caecum in 29/36 (81%) cases with a median transit time of 241 minutes. The difference in transit time was not significant (p = 0.061) in this material. The capsule was retained in the stomach in 3/18 patients. None of the patients developed symptoms or signs of mechanical obstruction.

Conclusion

A high frequency of mucosal breaks and signs of motility disturbances were seen in CID patients. CE is feasible for the examination of small bowel mucosa in patients with CID. The relevance of observed mucosal abnormalities in CID remains uncertain.

【 授权许可】

   
2007 Hoog et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rosa-E-Silva L, Gerson L, Davila M, Triadafilopoulos G: Clinical, radiologic, and manometric characteristics of chronic intestinal dysmotility: the Stanford experience. Clin Gastroenterol Hepatol 2006, 4:866-873.
• [2]Christensen J, Dent J, Malagelada JR, Wingate DL: Pseudo-obstruction. Gastroenterol Intl 1990, 3:107-119.
• [3]Mann SD, Debinski HS, Kamm MA: Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997, 41:675-681.
• [4]Wingate D, Hongo M, Kellow J, Lindberg G, Smout A: Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002, 17(Suppl):S1-14.
• [5]Hirano I, Pandolfino J: Chronic intestinal pseudo-obstruction. Dig Dis 2000, 18:83-92.
• [6]Stanghellini V, Cogliandro RF, De Giorgio R, Giovanni B, Morselli-Labate AM, Cogliandro L, Corinaldesi R: Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005, 3:449-458.
• [7]Iddan G, Meron G, Glukhovsky A, Swain P: Wireless capsule endoscopy. Nature 2000, 405:417.
• [8]Swain P, Adler D, Enns R: Capsule endoscopy in obscure intestinal bleeding. Endoscopy 2005, 37:655-659.
• [9]Barkin JS, O'Loughlin C: Capsule endoscopy contraindications: Complications and how to avoid their occurrence. Gastrointest Endoscopy Clin N Am 2004, 14:61-65.
• [10]Storch I, Barkin JS: Contraindications to capsule endoscopy: Do they still exist? Gastrointest Endosc Clin N Am 2006, 16:329-36.
• [11]Ohlsson B, Fork FT, Veress B, Toth E: Coexistent chronic idiopathic pseudo-obstruction and inflammatory bowel disease. Gut 2005, 54:729-730.
• [12]Carlo JT, DeMarco D, Smith BA, Livingstone S, Wiser K, Kuhn JA, Lamont JP: The utility of capsule endoscopy and its role for diagnosing pathology in the gastrointestinal tract. Am J Surg 2005, 190:886-890.
• [13]Cave D, Legnani P, De Franchis R, Lewis BS: ICCE consensus for capsule retention. Endoscopy 2005, 37:1065-1067.
• [14]Selby W: Complete small-bowel transit in patients undergoing capsule endoscopy: determining factors and improvement with metoclopramide. Gastrointest Endosc 2005, 61:80-85.
• [15]Lai L, Wong G, Chow D, Lau J, Sung J, Leung W: Inter-observer variations on interpretation of capsule endoscopies. Eur J Gastroenterol Hepatol 2006, 18:283-286.
• [16]Ben-Soussan E, Savoye G, Antonietti M, Ramirez S, Lerebours E, Ducrotte P: Factors that affect gastric passage of video capsule. Gastrointest Endosc 2005, 62:785-790.
• [17]Fireman Z, Paz D, Kopelman Y: Capsule endoscopy: improving transit time and image view. World J Gastroenterol 2005, 11:5863-5866.
• [18]Dai N, Gubler C, Hengstler P, Meyenberger C, Bauerfeind P: Improved capsule endoscopy after bowel preparation. Gastrointest Endosc 2005, 61:28-31.
• [19]Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, Rossini FP, De Franchis R: Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases. Gastroenterology 2004, 126:643-53.
• [20]Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazol, and placebo. Clin Gastroenterol Hepatol 2005, 3:133-141.
• [21]Pennazio M: Small-intestinal pathology on capsule endoscopy: inflammatory lesions. Endoscopy 2005, 37:769-775.
• [22]Fortun PJ, Hawkey CJ: Nonsteroidal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol 2005, 21:169-175.
• [23]Chutkan R, Toubia N: Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: Diagnosis by wireless capsule endoscopy. Gastrointest Endosc Clin N Am 2004, 14:67-86.
• [24]Panganamamula KV, Parkman HP: Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 2005, 8:3-11.
• [25]Barkin JS, Friedman S: Wireless capsule endoscopy requiring surgical intervention. The world's experience. Am J Gastroenterol 2002, 97:A-83.
• [26]Cheifetz AS, Lewis B: Capsule endoscopy retention: Is it a complication? J Clin Gastroenterol 2006, 40:688-691.
• [27]Rondonotti E, Herrerias JM, Pennazio M, Caunedo A, Mascarenhas-Saraiva M, De Franchis R: Complications, limitations, and failures of capsule enodscopy: a review of 733 cases. Gastrointest Endosc 2005, 62:852-856.
• [28]Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS: The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol 2006, 101:2218-2222.
• [29]Baichi MM, Arifuddin RM, Mantry PS: What have we learned from 5 cases of permanent capsule retention. Gastroinst Endosc 2006, 64:283-287.
• [30]Sears DM, Avots-Avontins A, Culp K, Gavin MW: Frequency and clinical outcome of capsule retention during capsule endoscopy for GI bleeding of obscure origin. Gastrointest Endosc 2004, 60:822-827.
• [31]Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT: Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hep 2004, 2:31-40.
• [32]Legnani P, Kornbluth A: Video capsule endoscopy in inflammatory bowel disease in 2005. Curr Opin Gastroenterol 2005, 21:438-442.